ERBB2 and hepatocellular carcinoma: Therefore, engineered T cells were tested against four additional non-TNBC cell lines including HCC-1954 and SK-BR-3 (HER2 enriched) MCF-7 and T-47-D (luminal A) (Dai et al, 2017), and three primary myoblasts (h-MB), skin fibroblasts (BJ), and lung fibroblasts (IMR-90) human cell lines (Fig 4D).